Peptide Hydrogels as Immunomaterials and Their Use in Cancer Immunotherapy Delivery

Abstract

Peptide‐based hydrogel biomaterials have emerged as an excellent strategy for immune system modulation. Peptide‐based hydrogels are supramolecular materials that self‐assemble into various nanostructures through various interactive forces (i.e., hydrogen bonding and hydrophobic interactions) and respond to microenvironmental stimuli (i.e., pH, temperature). While they have been reported in numerous biomedical applications, they have recently been deemed promising candidates to improve the efficacy of cancer immunotherapies and treatments. Immunotherapies seek to harness the body's immune system to preemptively protect against and treat various diseases, such as cancer. However, their low efficacy rates result in limited patient responses to treatment. Here, the immunomaterial's potential to improve these efficacy rates by either functioning as immune stimulators through direct immune system interactions and/or delivering a range of immune agents is highlighted. The chemical and physical properties of these peptide‐based materials that lead to immuno modulation and how one may design a system to achieve desired immune responses in a controllable manner are discussed. Works in the literature that reports peptide hydrogels as adjuvant systems and for the delivery of immunotherapies are highlighted. Finally, the future trends and possible developments based on peptide hydrogels for cancer immunotherapy applications are discussed.

Recent advances in peptide-based bioactive hydrogels for nerve repair and regeneration: from material design to fabrication, functional tailoring and applications

“…In the preparation of peptide hydrogels, noncovalent interactions, such as hydrogen bonding, electrostatic interactions, π–π interactions, and hydrophobic/hydrophilic interactions, as well as covalent interactions are responsible for the cross-linking between peptide molecules and other components to form the hydrogel network. 25,28…”

The quest for nanoparticle-powered vaccines in cancer immunotherapy

“…Several cutting-edge nanovaccines exhibit considerable promise for cancer immunotherapy, including personalized vaccines [ 134 ], cytomembrane nanovaccines [ 385 ], peptide-based vaccines [ 386 , 387 ] and nanodiscs [ 388 , 389 ]. These new nanovaccine strategies might revolutionize or improve cancer immunotherapy.…”

Applications of self-assembled peptide hydrogels in anti-tumor therapy

“…Vaccination has shown great promise in cancer immunotherapy, but inducing a robust and broad therapeutic CD8+ T-cell immunity against tumors remains challenging due to the inherent heterogeneity of tumor antigen expression. 118,119 Jia et al used arginine and fluorine phenylalanine as building blocks to synthesize a series of supramolecular self-assembling peptides. Among these peptides, 4RDP not only enhanced antigen uptake and maturation of DCs, but also facilitated lysosomal escape and antigen cross-presentation in DCs.…”